So far, the utility of serum KL-6 has been evaluated in several forms of ILD and its sensitivity and specificity for RA-ILD ranged from 67%-85% and 60%-90%, respectively, depending on the cutoff value (36, 37, 39). The gene discussed is MUC1; the disease is interstitial lung disease.